Merck & Co. Inc. (MRK): Price and Financial Metrics


Merck & Co. Inc. (MRK): $102.94

-0.52 (-0.50%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

MRK POWR Grades

  • Sentiment is the dimension where MRK ranks best; there it ranks ahead of 92.26% of US stocks.
  • The strongest trend for MRK is in Growth, which has been heading down over the past 177 days.
  • MRK's current lowest rank is in the Momentum metric (where it is better than 17.19% of US stocks).

MRK Stock Summary

  • With a market capitalization of $262,312,067,470, MERCK & CO INC has a greater market value than 99.49% of US stocks.
  • MRK's went public 37.12 years ago, making it older than 93.49% of listed US stocks we're tracking.
  • In terms of twelve month growth in earnings before interest and taxes, MERCK & CO INC is reporting a growth rate of 91.21%; that's higher than 84.98% of US stocks.
  • Stocks that are quantitatively similar to MRK, based on their financial statements, market capitalization, and price volatility, are PFE, LLY, ASML, ABBV, and NVO.
  • MRK's SEC filings can be seen here. And to visit MERCK & CO INC's official web site, go to www.merck.com.

MRK Valuation Summary

  • MRK's price/sales ratio is 4.6; this is 119.05% higher than that of the median Healthcare stock.
  • Over the past 243 months, MRK's price/sales ratio has gone up 2.2.

Below are key valuation metrics over time for MRK.

Stock Date P/S P/B P/E EV/EBIT
MRK 2023-01-30 4.6 6.1 17.6 17.2
MRK 2023-01-27 4.5 6.0 17.5 17.1
MRK 2023-01-26 4.6 6.1 17.8 17.3
MRK 2023-01-25 4.7 6.2 18.0 17.6
MRK 2023-01-24 4.7 6.2 18.0 17.6
MRK 2023-01-23 4.7 6.3 18.3 17.8

MRK Growth Metrics

    The 5 year cash and equivalents growth rate now stands at -36.58%.
  • Its 2 year price growth rate is now at 14.12%.
  • Its 5 year net cashflow from operations growth rate is now at 50.65%.
MRK's revenue has moved up $17,245,000,000 over the prior 49 months.

The table below shows MRK's growth in key financial areas (numbers in millions of US dollars).

Date Revenue Operating Cash Flow Net Income to Common Stock
2022-09-30 58,974 19,696 15,260
2022-06-30 57,169 18,891 16,579
2022-03-31 53,978 17,079 14,180
2021-12-31 48,704 14,109 13,049
2021-09-30 49,151 13,084 7,197
2021-06-30 48,548 10,460 5,571

MRK's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.
  • MRK has a Quality Grade of B, ranking ahead of 77.57% of graded US stocks.
  • MRK's asset turnover comes in at 0.535 -- ranking 75th of 682 Pharmaceutical Products stocks.
  • XTNT, ACOR, and BDSI are the stocks whose asset turnover ratios are most correlated with MRK.

The table below shows MRK's key quality metrics over time.

Period Asset Turnover Gross Margin ROIC
2021-06-30 0.535 0.675 0.129
2021-03-31 0.529 0.670 0.158
2020-12-31 0.538 0.677 0.171
2020-09-30 0.542 0.712 0.276
2020-06-30 0.550 0.701 0.260
2020-03-31 0.571 0.701 0.256

MRK Price Target

For more insight on analysts targets of MRK, see our MRK price target page. And for a list of of all stocks sorted by upside potential based on analyst target price, see our Top Price Target page.

Average Price Target $93.38 Average Broker Recommendation 1.52 (Moderate Buy)

MRK Stock Price Chart Interactive Chart >

Price chart for MRK

MRK Price/Volume Stats

Current price $102.94 52-week high $115.49
Prev. close $103.46 52-week low $72.88
Day low $102.48 Volume 11,210,800
Day high $103.79 Avg. volume 9,143,044
50-day MA $109.58 Dividend yield 2.84%
200-day MA $95.68 Market Cap 260.99B

Merck & Co. Inc. (MRK) Company Bio


Merck & Co., Inc.d.b.a. Merck Sharp & Dohme (MSD) outside the United States and Canada, is an American multinational pharmaceutical company headquartered in Kenilworth, New Jersey. It is named after the Merck family, which set up Merck Group in Germany in 1668. Merck & Co. was established as an American affiliate in 1891.(Source:Wikipedia)


MRK Latest News Stream


Event/Time News Detail
Loading, please wait...

MRK Latest Social Stream


Loading social stream, please wait...

View Full MRK Social Stream

Latest MRK News From Around the Web

Below are the latest news stories about MERCK & CO INC that investors may wish to consider to help them evaluate MRK as an investment opportunity.

Merck, Eli Lilly stocks fall over earnings, outlook concerns

Senior reporter Anjalee Khemlani joins Yahoo Finance Live to discuss how pharma stocks are faring after reporting earnings.

Yahoo | February 2, 2023

Merck (MRK) Q4 2022 Earnings Call Transcript

Speaking on today's call will be Rob Davis, chairman and chief executive officer; Caroline Litchfield, chief financial officer; and Dean Li, president of Merck Research Labs. Such statements are made based on the current beliefs of Merck's management and are subject to significant risks and uncertainties. If our underlying assumptions prove inaccurate or uncertainties materialize, actual results may differ materially from those set forth in the forward-looking statements.

Yahoo | February 2, 2023

Pharma earnings: COVID ‘is highly uncertain for this year,’ analyst says

Wells Fargo Managing Director Mohit Bansal joins Yahoo Finance Live to discuss pharmaceutical earnings amid COVID uncertainty, the impact of diabetic weight loss drugs on the market, and the outlook for drugmakers. 

Yahoo | February 2, 2023

Merck’s COVID-19 pill linked to new virus mutations: Study

Yahoo Finance’s Anjalee Khemlani joins the Live show to explain a new study that suggests a link between Merck’s COVID-19 pill and new virus mutations, though Merck has denied these claims.

Yahoo | February 2, 2023

Merck (MRK) Beats on Q4 Earnings & Sales, 2023 View Disappoints

Merck (MRK) beats Q4 estimates for earnings and sales. Its 2023 profit guidance disappoints. Stock declines in pre-market.

Yahoo | February 2, 2023

Read More 'MRK' Stories Here

MRK Price Returns

1-mo -9.42%
3-mo 4.46%
6-mo 18.04%
1-year 35.25%
3-year 32.36%
5-year 113.25%
YTD -7.22%
2022 49.42%
2021 -2.91%
2020 -7.20%
2019 22.27%
2018 39.95%

MRK Dividends

Ex-Dividend Date Type Payout Amount Change
Loading, please wait...
View Full MRK Dividend History

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!


Page generated in 0.6021 seconds.